<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-11-16" updated="2019-12-02">
  <drugbank-id primary="true">DB09316</drugbank-id>
  <name>Thallous Chloride</name>
  <description>Thallous chloride (also known as Thallium(I) chloride) is a colourless solid intermediate in the isolation of thallium from its ores. It is created from the treatment of thallium(I) sulfate with hydrochloric acid. This solid crystallizes in the caesium chloride motif. It is used as a diagnostic radiopharmaceutical. It is used for diagnosis of heart and parathyroid problems. The following are among the possible side effects: Blurred vision, chest pain or discomfort, chills, confusion, cough, difficulty with breathing, difficulty with swallowing, and dizziness.</description>
  <cas-number>7791-12-0</cas-number>
  <unii>37CB58V15B</unii>
  <average-mass>239.836</average-mass>
  <monoisotopic-mass>239.943264977</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links>
      <link>
        <ref-id>L226</ref-id>
        <title>Monograph</title>
        <url>https://www.drugs.com/sfx/thallous-chloride-tl-201-side-effects.html</url>
      </link>
    </links>
    <attachments/>
  </general-references>
  <synthesis-reference/>
  <indication>For use as a diagnostic radiopharmaceutical.&#13;
It is indicated to help diagnose heart disease (eg, coronary artery disease, heart attack). It is also used for the diagnosis of parathyroid problems. </indication>
  <pharmacodynamics>Data not found.</pharmacodynamics>
  <mechanism-of-action>Thallous Chloride TI201 without carrier, accumulates in the heart (myocardium) in a similar way to that of potassium. Thallous Chloride Tl 201 images have been found to visualize areas of infarction as “cold” or nonlabeled regions which are confirmed by electrocardiographic and enzyme changes. Regions of transient myocardial ischemia corresponding to areas perfused by coronary arteries with partial stenoses have been visualized when Thallous Chloride Tl 201 was administered in conjunction with an exercise stress test. Anatomic configurations may interfere with visualization of the right coronary artery.</mechanism-of-action>
  <toxicity> LD50 (mouse): 24 mg/kg.&#13;
 Minimum lethal dose (Human): 8 mg/kg.&#13;
Thallium inhibits enzymes, but nothing is really known of a biochemical lesion. In fatal cases, there usually is extensive peripheral paralysis and cardiovascular involvement. The immediate cause of death may be peripheral respiratory failure of cardiac arrest.</toxicity>
  <metabolism>Data not found</metabolism>
  <absorption>After IV administration, thallous chloride clears rapidly from the blood, with maximum concentration in the myocardium after about 10 min.&#13;
Only 5-8% of injected activity remained in the blood, following 5 minutes of intravenous administration.</absorption>
  <half-life>91% of the blood radioactivity has a t1/2 of 5 min.&#13;
9% has t1/2 of 40 hours.</half-life>
  <protein-binding>Data not found.</protein-binding>
  <route-of-elimination>Thallous Chloride Tl 201 is excreted slowly and to an equal extent in both feces and urine.</route-of-elimination>
  <volume-of-distribution>3–10 L/kg</volume-of-distribution>
  <clearance>Approximately 4-8% of the injected dose was excreted in the urine in the first 24 hours. The whole body disappearance half-time was 9.8 ± 2.5 days. Kidney concentration was found to be about 3 percent of the injected activity and the testicular content was 0.15 percent. Net thyroid activity was determined to be only 0.2 percent of the injected dose, and the activity disappeared in 24 hours. From anterior and posterior whole-body scans, it was determined that about 45 percent of the injected dose was in the large intestines and contiguous structures (liver, kidneys, abdominal musculature).</clearance>
  <classification>
    <description>This compound belongs to the class of inorganic compounds known as post-transition metal chlorides. These are inorganic compounds in which the largest halogen atom is Chlorine, and the heaviest metal atom is a post-transition metal.</description>
    <direct-parent>Post-transition metal chlorides</direct-parent>
    <kingdom>Inorganic compounds</kingdom>
    <superclass>Mixed metal/non-metal compounds</superclass>
    <class>Post-transition metal salts</class>
    <subclass>Post-transition metal chlorides</subclass>
    <alternative-parent>Inorganic chloride salts</alternative-parent>
    <substituent>Inorganic chloride salt</substituent>
    <substituent>Inorganic salt</substituent>
    <substituent>Post-transition metal chloride</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">Thallium chloride</synonym>
    <synonym language="english" coder="iupac">thallium monochloride</synonym>
    <synonym language="english" coder="">Thallium(I) chloride</synonym>
    <synonym language="english" coder="">Thallous Chloride Tl-201</synonym>
  </synonyms>
  <products>
    <product>
      <name>Thallous Chloride Tl 201</name>
      <labeller>Medi-Physics, Inc. dba GE Healthcare</labeller>
      <ndc-id/>
      <ndc-product-code>17156-299</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1982-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, powder, lyophilized, for solution</dosage-form>
      <strength>1 mCi/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA018110</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>THALLOUS CHLORIDE Tl 201</name>
      <labeller>Curium US LLC</labeller>
      <ndc-id/>
      <ndc-product-code>69945-120</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-11-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 mCi/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA018150</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Thallous Chloride Tl 201</name>
      <labeller>Lantheus Medical Imaging</labeller>
      <ndc-id/>
      <ndc-product-code>11994-427</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1977-12-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2 mCi/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA017806</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Thallous Chloride Tl 201</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>13483-201</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-09-04</started-marketing-on>
      <ended-marketing-on>2013-09-05</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>2 mCi/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA077698</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>THALLOUS CHLORIDE Tl 201</name>
      <labeller>Mallinckrodt</labeller>
      <ndc-id/>
      <ndc-product-code>0019-9120</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-29</started-marketing-on>
      <ended-marketing-on>2017-07-01</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 mCi/1mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA018150</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Thallous Chloride Tl 201</name>
      <ingredients>Thallous Chloride</ingredients>
    </mixture>
    <mixture>
      <name>THALLOUS CHLORIDE Tl 201</name>
      <ingredients>Thallous Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Thallous Chloride Tl 201</name>
      <ingredients>Thallous Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Thallous Chloride Tl 201</name>
      <ingredients>Thallous Chloride</ingredients>
    </mixture>
    <mixture>
      <name>THALLOUS CHLORIDE Tl 201</name>
      <ingredients>Thallous Chloride</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Elements</category>
      <mesh-id>D004602</mesh-id>
    </category>
    <category>
      <category>Metals</category>
      <mesh-id>D008670</mesh-id>
    </category>
    <category>
      <category>Metals, Heavy</category>
      <mesh-id>D019216</mesh-id>
    </category>
    <category>
      <category>Radioactive Diagnostic Agent</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous</route>
      <strength>1 mCi/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1 mCi/1mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>2 mCi/1mL</strength>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries/>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.55</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.29</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.23e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>0.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>chlorothallane</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>thallous chloride</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>239.836</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>239.943264977</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[Cl-].[Tl+]</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>ClTl</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/ClH.Tl/h1H;/q;+1/p-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>GBECUEIQVRDUKB-UHFFFAOYSA-M</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>6.14</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>4.35</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties/>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>37117</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>24642</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>310265201</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C15226</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>23044</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Thallium(I)_chloride</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2110567</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>